(19)
(11) EP 1 334 358 A1

(12)

(43) Date of publication:
13.08.2003 Bulletin 2003/33

(21) Application number: 00968724.5

(22) Date of filing: 03.10.2000
(51) International Patent Classification (IPC)7G01N 33/50, C12Q 1/68, A61K 38/00, A61P 35/00
(86) International application number:
PCT/US0027/462
(87) International publication number:
WO 0304/4525 (30.05.2003 Gazette 2003/22)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: Regents of the University of California
Oakland, CA 94720-1620 (US)

(72) Inventors:
  • BEDALOV, Antonio
    Seattle WA 98144 (US)
  • FOSS, Eric
    Seattle WA 98103 (US)
  • PADDISON, Patrick
    Oyster Bay NY 1171 (US)
  • FRIEND, Steve
    Seattle WA 98144 (US)

(74) Representative: Luderschmidt, Schüler & Partner GbR 
Patentanwälte,John-F.-Kennedy-Strasse 4
65189 Wiesbaden
65189 Wiesbaden (DE)

   


(54) TARGETING CELLS HAVING MAD2 MUTATION FOR TREATMENT AND/OR PREVENTION OF DISEASE